Pharmacological approaches to coronary microvascular dysfunction.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Pharmacology and Therapeutics

• Publication date

  2014-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.pharmthera.2014.06.008PMID 25004087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: results from an international multicentre retrospective cohort study.

  2013cited by this paper
• Efficacy of trimetazidine on functional capacity in symptomatic patients with stable exertional angina--the VASCO-angina study.

  2013cited by this paper
• Lack of Effect of Nitrates on Exercise Stress Test Results in Patients with Microvascular Angina

  2013cited by this paper
• Protective effects of fasudil hydrochloride post-conditioning on acute myocardial ischemia/reperfusion injury in rats.

  2013cited by this paper
• Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

  2013cited by this paper
• Nox2 NADPH Oxidase Has a Critical Role in Insulin Resistance–Related Endothelial Cell Dysfunction

  2013cited by this paper
• Impaired coronary microvascular reactivity in women with apical ballooning syndrome (Takotsubo/stress cardiomyopathy)

  2013cited by this paper
• Role of adenosine as an adjunct therapy in the prevention and treatment of no-reflow phenomenon in acute myocardial infarction with ST segment elevation: review of the current data.

  2013cited by this paper
• Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.

  2013cited by this paper
• Systemic and Vascular Oxidation Limits the Efficacy of Oral Tetrahydrobiopterin Treatment in Patients With Coronary Artery Disease

  2012cited by this paper
• Reduction of Ischemia/Reperfusion Injury With Bendavia, a Mitochondria-Targeting Cytoprotective Peptide

  2012cited by this paper
• Targeting NADPH oxidases in vascular pharmacology.

  2012cited by this paper
• Endothelial Dysfunction in Diabetes Mellitus: Possible Involvement of Endoplasmic Reticulum Stress?

  2012cited by this paper
• Abstract 11818: Long-Term Administration of Pioglitazone Added to Statin Reverses Vasomotor Dysfunction of Coronary Arteries Irrespective of Improvements in Diabetic Status

  2012cited by this paper
• Telmisartan acts through the modulation of ACE-2/ANG 1-7/mas receptor in rats with dilated cardiomyopathy induced by experimental autoimmune myocarditis.

  2012cited by this paper
• Disruption of TRPV1-mediated coupling of coronary blood flow to cardiac metabolism in diabetic mice: role of nitric oxide and BK channels.

  2012cited by this paper
• High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries).

  2012cited by this paper
• Nicorandil

  2012cited by this paper
• Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid

  2012cited by this paper
• Correlations between Endothelial Functions and ROS Detection in Diabetic Microvascular Wall: Early and Late Ascorbic Acid Supplementation

  2012cited by this paper
• Resolution of Mitochondrial Oxidative Stress Rescues Coronary Collateral Growth in Zucker Obese Fatty Rats

  2012cited by this paper
• Microvascular dysfunction in nonfailing arrhythmogenic right ventricular cardiomyopathy

  2012cited by this paper
• Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12

  2011cited by this paper
• Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction

  2011cited by this paper
• Ivabradine improves coronary flow reserve in patients with stable coronary artery disease.

  2011cited by this paper
• Inhibition of NADPH oxidase alleviates experimental diabetes‐induced myocardial contractile dysfunction

  2011cited by this paper
• In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia

  2011cited by this paper
• Postconditioning protects against human endothelial ischaemia-reperfusion injury via subtype-specific KATP channel activation and is mimicked by inhibition of the mitochondrial permeability transition pore.

  2011cited by this paper
• High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction.

  2011cited by this paper
• Chronic resveratrol treatment restores vascular responsiveness of cerebral arterioles in type 1 diabetic rats.

  2011cited by this paper
• Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease.

  2011cited by this paper
• Olmesartan, an AT1 Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis

  2011cited by this paper
• Diphenyl Diselenide Effectively Reduces Atherosclerotic Lesions in LDLr −/− Mice by Attenuation of Oxidative Stress and Inflammation

  2011cited by this paper
• Modulating fatty acid oxidation in heart failure.

  2011cited by this paper
• Reactivity of the aorta and mesenteric resistance arteries from the obese spontaneously hypertensive rat: effects of glitazones.

  2011cited by this paper
• Preparation and effects of 2,3‐dehydrosilymarin, a promising and potent antioxidant and free radical scavenger

  2011cited by this paper
• Rapid, Direct Effects of Statin Treatment on Arterial Redox State and Nitric Oxide Bioavailability in Human Atherosclerosis via Tetrahydrobiopterin-Mediated Endothelial Nitric Oxide Synthase Coupling

  2011cited by this paper
• Oxidative damage of mitochondrial DNA in diabetes and its protection by manganese superoxide dismutase

  2010cited by this paper
• Trimetazidine inhibits pressure overload-induced cardiac fibrosis through NADPH oxidase-ROS-CTGF pathway.

  2010cited by this paper
• Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: possible role of oxidative/nitrosative stress attenuation

  2010cited by this paper
• Exogenous SOD mimetic tempol ameliorates the early retinal changes reestablishing the redox status in diabetic hypertensive rats.

  2010cited by this paper
• Dehydrosilybin attenuates the production of ROS in rat cardiomyocyte mitochondria with an uncoupler-like mechanism

  2010cited by this paper
• Modulation of myocardial metabolism: an emerging therapeutic principle

  2010cited by this paper
• Lack of Glutathione Peroxidase 1 Accelerates Cardiac-Specific Hypertrophy and Dysfunction in Angiotensin II Hypertension

  2010cited by this paper
• Role of NAD(P)H Oxidase in Superoxide Generation and Endothelial Dysfunction in Goto-Kakizaki (GK) Rats as a Model of Nonobese NIDDM

  2010cited by this paper
• Simvastatin attenuates cardiopulmonary bypass-induced myocardial inflammatory injury in rats by activating peroxisome proliferator-activated receptor γ.

  2010cited by this paper
• Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling.

  2010cited by this paper
• Abstract 17047: Role of Mitochondrial Function and Mitochondrial DNA Integrity in Coronary Metabolic Dilation

  2010cited by this paper
• Apocynin restores endothelial dysfunction in streptozotocin diabetic rats through regulation of nitric oxide synthase and NADPH oxidase expressions.

  2010cited by this paper
• Metabolic Modulator Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy

  2010cited by this paper
• Glutathione peroxidase 1 protects mitochondria against hypoxia/reoxygenation damage in mouse hearts

  2010cited by this paper
• Antiatherosclerotic and Renoprotective Effects of Ebselen in the Diabetic Apolipoprotein E/GPx1-Double Knockout Mouse

  2010cited by this paper
• Resveratrol induces mitochondrial biogenesis in endothelial cells

  2009cited by this paper
• A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images.

  2009cited by this paper
• Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.

  2009cited by this paper
• Rosuvastatin Increases Extracellular Adenosine Formation in Humans In Vivo: A New Perspective on Cardiovascular Protection

  2009cited by this paper
• Role of MCP-1 in tumor necrosis factor-alpha-induced endothelial dysfunction in type 2 diabetic mice.

  2009cited by this paper
• Ranolazine Antagonizes the Effects of Increased Late Sodium Current on Intracellular Calcium Cycling in Rat Isolated Intact Heart

  2009cited by this paper
• Uncouple my heart: the benefits of inefficiency

  2009cited by this paper
• Abstract 5252: Long-Term Administration of Thiazolidinedione Improves Vasomotion of Coronary Arteries Irrespective of Improvements in Diabetic Status for Patients Receiving an Angiotensin-II Receptor Blocker

  2009cited by this paper
• Improvement of neovascularization capacity of bone marrow mononuclear cells from diabetic mice by ex vivo pretreatment with resveratrol

  2009cited by this paper
• L-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease.

  2009cited by this paper
• Impact of rosiglitazone and glyburide on nitrosative stress and myocardial blood flow regulation in type 2 diabetes mellitus.

  2009cited by this paper
• Apocynin improves endothelial function and prevents the development of hypertension in fructose fed rat

  2009cited by this paper
• Persistent chest pain and no obstructive coronary artery disease.

  2009cited by this paper
• Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARγ stimulation

  2009cited by this paper
• Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells

  2009cited by this paper
• Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms.

  2009cited by this paper
• Diabetic cardiopathy. Quantitative histological studies of the heart from young juvenile diabetics.

  2009cited by this paper
• Adenosine inhibition of adenosine diphosphate and thrombin-induced monocyte-platelet aggregates in cardiac syndrome X.

  2009cited by this paper
• Glutathione peroxidase deficiency exacerbates ischemia-reperfusion injury in male but not female myocardium: insights into antioxidant compensatory mechanisms.

  2009cited by this paper
• Role of MCP-1 in tumor necrosis factor- (cid:1) -induced endothelial dysfunction in type 2 diabetic mice

  2009cited by this paper
• Effect of cyclosporine on reperfusion injury in acute myocardial infarction.

  2008cited by this paper
• Identification by a differential proteomic approach of the induced stress and redox proteins by resveratrol in the normal and diabetic rat heart

  2008cited by this paper
• Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition.

  2008cited by this paper
• Statins ameliorate atherosclerosis induced by inhibition of nitric oxide synthase: another novel vascular protective mechanism?

  2008cited by this paper
• Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant

  2008cited by this paper
• Effect of intra-coronary nicorandil administration prior to reperfusion in acute ST segment elevation myocardial infarction.

  2008cited by this paper
• Supplementation of α-tocopherol improves cardiovascular risk factors via the insulin signalling pathway and reduction of mitochondrial reactive oxygen species in type II diabetic rats

  2008cited by this paper
• Beneficial effect of post-procedural abciximab in patients undergoing primary coronary angioplasty and presenting with the no-reflow phenomenon

  2008cited by this paper
• NOX enzymes as novel targets for drug development

  2008cited by this paper
• Inhibition of GSK3β by Postconditioning Is Required to Prevent Opening of the Mitochondrial Permeability Transition Pore During Reperfusion

  2008cited by this paper
• Administration of the Rho-kinase inhibitor, fasudil, following nitroglycerin additionally dilates the site of coronary spasm in patients with vasospastic angina

  2008cited by this paper
• Classical inhibitors of NOX NAD(P)H oxidases are not specific.

  2008cited by this paper
• Angioplasty Strategies in ST-Segment–Elevation Myocardial Infarction: Part II: Intervention After Fibrinolytic Therapy, Integrated Treatment Recommendations, and Future Directions

  2008cited by this paper
• Mitochondria-Targeted Cytoprotective Peptides for Ischemia–Reperfusion Injury

  2008cited by this paper
• Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy

  2008cited by this paper
• Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT.

  2008cited by this paper
• AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice.

  2008cited by this paper
• Angiography : A Randomized Controlled Trial CoronaryWith Homocysteine-Lowering B Vitamins After Mortality and Cardiovascular Events in Patients Treated

  2008cited by this paper
• Restoration of coronary collateral growth in the Zucker obese rat:

  2007cited by this paper
• Deficiency of Glutathione Peroxidase-1 Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice

  2007cited by this paper
• Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus

  2007cited by this paper
• Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy

  2007cited by this paper
• Myocardial reperfusion injury.

  2007cited by this paper
• Pretreatment with statins may reduce cardiovascular morbidity and mortality after elective surgery and percutaneous coronary intervention: clinical evidence and possible underlying mechanisms.

  2007cited by this paper
• Targeting antioxidants to mitochondria and cardiovascular diseases: the effects of mitoquinone.

  2007cited by this paper
• Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials.

  2007cited by this paper
• Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy.

  2007cited by this paper
• Endothelial function and dysfunction: testing and clinical relevance.

  2007cited by this paper

• Known yet underdiagnosed: Invasive assessment of coronary microvascular disease and its implications

  2025cites this paper
• Микроваскулярная стенокардия: эволюция взглядов на эпидемиологию, диагностику, лечение, физическую реабилитацию и прогноз с учетом изменяющейся парадигмы ишемии миокарда

  2025cites this paper
• Design and rationale of the efficacy of endothelin receptor antagonism in treatment of coronary artery spasm: a randomized controlled trial (EDIT-CAS).

  2025cites this paper
• ANOCA updated: From pathophysiology to modern clinical practice.

  2024cites this paper
• Hepato-protective effects of aqueous extract of Ficus dicranostyla Mildbr. (Moraceae) leaves on paracetamol-induced hepatotoxicity in Wistar rats

  2024cites this paper
• Bridging the Gender Gap in Cardiovascular Medicine: Addressing Drug Intolerances and Personalized Care for Women with Angina/Ischemia with Non-Obstructive Coronary Artery Disease

  2024cites this paper
• 2024 ESC Guidelines for the management of chronic coronary syndromes.

  2024cites this paper
• A Practical Approach to Invasive Testing in Ischemia With No Obstructive Coronary Arteries (INOCA)

  2022cites this paper
• Ischemia with No Obstructive Arteries (INOCA): A review of the prevalence, diagnosis and management.

  2022cites this paper
• Molecular mechanisms of coronary microvascular endothelial dysfunction in diabetes mellitus: focus on mitochondrial quality surveillance

  2022cites this paper
• Angiogenic CD34 Stem Cell Therapy in Coronary Microvascular Repair—A Systematic Review

  2021cites this paper
• Assessment of Myocardial Salvage Index after Primary Percutaneous Intervention of ST Elevation Myocardial Infarction Patients Using Myocardial Magnetic Resonance Imaging Techniques

  2021influential citation
• 13 (2) January 2021 CVJ.pmd

  2021cites this paper
• Effect of nicorandil combined with trimetazidine on miR-223-3p and NRF2 expression in patients with coronary heart disease.

  2021cites this paper
• Effects of three types of bariatric interventions on myocardial infarct size and vascular function in rats with type 2 diabetes mellitus.

  2021cites this paper
• No-Reflow after PPCI—A Predictor of Short-Term Outcomes in STEMI Patients

  2020cites this paper
• An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group.

  2020cites this paper
• An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group.

  2020cites this paper
• Predictors of suboptimal coronary blood flow after primary angioplasty and its implications on short-term outcomes in patients with acute anterior STEMI

  2020cites this paper
• Elevated renalase levels in patients with acute coronary microvascular dysfunction - A possible biomarker for ischemia.

  2019cites this paper
• Ocular and systemic vascular alterations in overweight and obese individuals undergoing weight-loss interventions

  2018cites this paper
• Treatment of Angina: Where Are We?

  2018cites this paper
• Trimetazidine and Other Metabolic Modifiers.

  2018cites this paper
• Physiological Consequences of Coronary Arteriolar Dysfunction and Its Influence on Cardiovascular Disease.

  2018cites this paper
• Relation of hemoglobin level to no-reflow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention

  2018cites this paper
• High glucose decreases claudins-5 and -11 in cardiac microvascular endothelial cells: Antagonistic effects of tongxinluo

  2017cites this paper
• Coronary microcirculatory pathophysiology: can we afford it to remain a black box?

  2016cites this paper
• Microvascular Dysfunction as Opposed to Conduit Artery Disease Explains Sex-specific Chest Pain in Emergency Department Patients With Low to Moderate Cardiac Risk.

  2016cites this paper
• Pharmacological Agents Targeting Myocardial Metabolism for the Management of Chronic Stable Angina : an Update

  2016cites this paper
• The no-reflow phenomenon: State of the art.

  2015cites this paper
• Gynecardiology: Distinct patterns of ischemic heart disease in middle-aged women.

  2015cites this paper
• Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography.

  2015cites this paper